Novel pestilence DNA vaccine and its construction and application
A technology of DNA vaccine and Newcastle disease, which is applied in the field of DNA vaccine and its construction and application, can solve the problems of low antibody titer, weak preventive effect, and poor immune effect, and achieve strong immune effect, safe genetic immunity, and convenient operation Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0024] Embodiment 1. Newcastle disease DNA vaccine of the present invention---the construction of pVAX1-LasotaHN DNA vaccine
[0025] The construction steps of pVAX1-LasotaHN DNA vaccine of the present invention are as follows:
[0026] 1) Extraction and purification of NDV virus (Virus) total RNA:
[0027] The RNAgents Total RNA Isolation System kit of Promega Company was used to extract the total RNA of NDV Lasota virus, and its specific operation was to use the NDV Lasota E 4 The virus strain was injected into chicken embryos incubated for 14 days. After the death of the chicken embryos was observed under the light, 20ml of allantoic fluid was collected, and the collected allantoic fluid was centrifuged at 700rpm for 15 minutes; the supernatant was added to 20ml of 16wt% PEG-0.525MNaCl, ice bath for 1 hour; centrifuge at 10,000rpm for 5 minutes, precipitate virus particles at 4°C; dissolve the virus pellet with 800μl denaturation solution, transfer to 1.5ml EP tube; add 80...
Embodiment 2
[0035] Example 2. Identification of exogenous LasotaHN gene in vitro transient expression and expression content of pVAX1-LasotaHN DNA vaccine
[0036] In vitro mRNA expression of LasotaHN gene: establishment of transient expression system for HeLa cells in vitro, the eukaryotic expression plasmid pVAX1-LasotaHN constructed in Example 1 was transfected into HeLa cells cultured in 24-well plates through liposomes, collected in 36 hours Cells, the total RNA of transfected HeLa cells collected at 36 hours was extracted, and the expression of LasotaHN gene in vitro was analyzed by RT-PCR method. The LasotaHN cDNA band was amplified by RT-PCR, and the results showed that the pVAX1-LasotaHN eukaryotic expression plasmid could be efficiently expressed at the mRNA level in the Hela cell in vitro transient expression system, and the expression level of the mRNA level was higher than that of the control group (empty plasmid ) was 157% higher.
[0037] In vitro protein expression of exo...
Embodiment 3
[0038] Example 3. Identification of exogenous LasotaHN gene expression and expression content of pVAX1-LasotaHN DNA vaccine in vivo
[0039] In vivo expression detection of exogenous LasotaHN gene: Three yellow chickens incubated in Beijing Changping chicken factory were randomly divided into 2 groups, each with 18 chickens, one group was the experimental group, and 20 μg of the pVAX1-LasotaHN plasmid constructed in Example 1 was injected intramuscularly into the three yellow chickens DNA; the other group was the control group, and 20 μg pVAX1 empty plasmid DNA was injected intramuscularly into the three yellow chickens. Three weeks after the injection of the plasmid DNA, the muscle, liver and spleen tissues of the three-yellow chicken immunized with pVAX1-LasotaHN were extracted, and the total RNA of the muscle tissue, liver and spleen tissue collected from the three-yellow chicken immunized with pVAX1-LasotaHN was extracted, and the exogenous LasotaHN gene was detected in the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com